Summary
Saudi Arabia represents one of the richest economies of the world. The country has witnessed many rapid changes in people's lifestyle, eating habits and social system over the last few years. These transformations at the social and individual levels have brought changes in diseases profiles and statistics. Hence, the prevalence of lifestyle and chronic diseases has been continuously increasing for last few years, which has put an additional burden on the healthcare spending in the country. From investors' point of view, the Saudi Arabian healthcare sector seems to be very promising and is expected to outpace the growth rate of other countries in the Middle East region in coming years.

Our new research report "Saudi Arabian Healthcare Market Forecast to 2012" states that the healthcare sector in Saudi Arabia is expected to enjoy a double-digit growth in future. All the three segments of the healthcare industry (hospital, pharmaceutical and medical devices) will post strong growth in the backdrop of strong demand and government support. For instance-the pharmaceutical market and medical devices market are projected to grow at a CAGR of around 10% and 12% respectively during 2010-2012. Besides, the most noticeable aspect of the healthcare industry is huge private investments and this trend is likely to continue in near future.

Our report has found that the demand for hospitals beds will escalate at rapid pace with changing country's demographic conditions and rising population. The increasing prevalence of diseases and expanding proportion of ageing population will further boost the demand for beds. However, there are several factors, like high cost of healthcare treatments in the country, economic dependency of the country on oil rates, which are imposing a negative impact on the growth rate, but these are expected to be overcome in near future with the help of government efforts.

This report contains valuable information and rational analysis of the Saudi Arabian healthcare market and its various aspects like health insurance. It provides an extensive research (data, trend analysis, demand, etc.) to pharmaceutical & healthcare companies and investors looking to foray into this market. The report also includes analysis and statistics of market size, growth, share, regulatory environment, key players and trends in technology development to present a comprehensive overview of the market to clients.

Table of Contents
1. Analyst View
2. Research Methodology
3. Market Drivers
    3.1 Macroeconomic and Healthcare Profile
    3.2 Increasing Prevalence of Chronic Diseases
    3.3 Rapidly Growing Population
    3.4 Strong Government Support
    3.5 Health Insurance
4. Emerging Market Trends
    4.1 Focus on Latest Technology & Innovation
    4.2 Consolidation & Mutual Co-operation-Gaining Popularity
    4.3 Creating Awareness
    4.4 Gaining Research & Development Edge
    4.5 Training Healthcare Professionals
    4.6 Construction of New Hospitals
5. Hospital Services Market
    5.1 Hospital Bed Capacity
          5.1.1 MOH Hospitals
          5.1.2 Other Government Hospitals
          5.1.3 Private Hospitals
    5.2 Hospital Beds Demand Projection (2010-2012)
    5.3 Hospital Occupancy Rate and Average Length of Stay
    5.4 Investment and Infrastructure Projection (2010-2012)
    5.5 Hospital Health Force
6. Pharmaceutical Market
    6.1 Market Overview
    6.2 Import and Domestic Production
    6.3 Branded and Generic Drugs
7. Medical Device Market
    7.1 Market Overview
    7.2 Market Segmentation
    7.3 Import and Domestic Production
8. Industry Restraints
    8.1 Staff Shortage
    8.2 Bureaucracy and Reform Delays
    8.3 Medical Tourism
9. Regulatory Environment
    9.1 Medical Device Regulation
    9.2 Pharmaceuticals and Drugs Regulatory Environment
10. Competitive Landscape
    10.1 Sanofi-Aventis
    10.2 TABUK Pharmaceutical Manufacturing
    10.3 King Faisal Specialist Hospital and Research Centre
    10.4 King Fahad Armed Forces Hospital
    10.5 Saad Specialist Hospital

List of Figures:

Figure 3-1: Leading Causes of Death (%)
Figure 3-2: Forecast for Leading Causes of Death (%), 2012
Figure 3-3: Forecast for Prevalence of Diabetes in Age Group 20-79 Years (%), 2010 & 2025
Figure 3-4: Relative Cost per Person by Number of Chronic Conditions
Figure 3-5: Population (Million), 2006, 2008 & 2012
Figure 3-6: Population Aged 65 Years and Above ('000), 2006, 2008 & 2012
Figure 3-7: Health Insurance Premium (Billion SAR), 2008-2012
Figure 5-1: Number of Hospital Beds (2005-2009)
Figure 5-2: Hospital Beds by Institution (%), 2009
Figure 5-3: Hospitals by Institution (%), 2009
Figure 5-4: Forecast for Additional Demand of Number of Hospital Beds (2010-2012)
Figure 5-5: Forecast for Distribution of Incremental Bed Capacity by Institution (%), 2010 to 2012
Figure 5-6: Forecast for Investment Required (Billion SAR), 2010-2012
Figure 5-7: Budget Allocated for Healthcare and Social Services (Billion SAR), 2008-2010
Figure 5-8: Health Workers by Nationality (%), 2008
Figure 6-1: Pharmaceutical Market (Billion SAR), 2007-2012
Figure 6-2: Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2009)
Figure 6-3: Pharmaceutical Imports by Region (%), 2006
Figure 6-4: Share of Generics and Branded Drugs in Pharmaceutical Market (2009)
Figure 6-5: Share of OTC and Prescription Drugs in Pharmaceutical Market (2008)
Figure 7-1: Medical Device Market (Million US$), 2006-2012
Figure 7-2: Medical Equipment Imports by Major Categories (%) 2006
Figure 7-3: Medical Supplies Imports by Major Categories (%), 2006
Figure 7-4: Share of Imported and Domestically Manufactured Devices in Medical Device Market (2009)

List of Tables:

Table 3-1: Key Macroeconomic Indicators (2006-2009)
Table 3-2: Key Demographics and Healthcare Indicators (2006-2009)
Table 3-3: Forecast for Key Demographics and Healthcare Indicators (2010-2012)
Table 3-4: Leading Causes of Death (Numbers)
Table 3-5: Healthcare Spending Statistics (2006-2009)
Table 3-6: Forecast for Healthcare Spending Statistics (2010-2012)
Table 3-7: Prevalence of Overweight and Obesity in Males and Females (%), 2005 & 2015
Table 3-8: Population Growth Rates in Major Countries (%), 2000 to 2015
Table 5-1: Hospital Beds Ratio of Selected Countries (per '000 Population)
Table 5-2: Number of MOH Hospitals by Specialty (2008)
Table 5-3: Number of MOH Hospital Beds by Specialty (2008)
Table 5-4: Number of Other Government Hospital Beds by Specialty (2008)
Table 5-5: Number of Private Healthcare Facilities by Type (2008)
Table 5-6: Number of Private Hospital Beds by Specialty (2008)
Table 5-7: Number of Private Clinics by Specialty (2008)
Table 5-8: Average Length of Stay in different Types of Hospitals
Table 5-9: Number of Physicians by Institution (2003 & 2008)
Table 5-10: Number of Nurses by Institution (2003 & 2008)
Table 5-11: Number of Allied Health Workers by Institution (2003 & 2008)
Table 6-1: Share of Top Ten Drugs in Pharmaceutical Market by Sales Value (Q3 2007)
Table 6-2: Share of Top Ten Drugs in Pharmaceutical Market by Sales Volume (Q3 2007)
Table 6-3: Share of Top Ten Players in Pharmaceutical Market by Sales Value (Q3 2007)